Irving Weissman

Irving Weissman

Direktor/Vorstandsmitglied bei
Institute For Stem Cell Biology & Regenerative Medicine
86 Jahre
Health Technology
Commercial Services
Finance

Profil

Irving L.
Weissman
is the founder of Systemix, Inc. founded in 1988.
Dr. Weissman was the founder of Forty Seven LLC founded in 2014 and served as Independent Director from 2015 to 2020.
Dr. Weissman was the founder of Cellerant Therapeutics, Inc. founded in 2003 and served as Director.
Dr. Weissman was the founder of Bitterroot Bio, Inc. founded in 2021 and served as Director.
Dr. Weissman is also the founder of Pheast Therapeutics, Inc...
Dr. Weissman is currently Director at the Institute For Stem Cell Biology & Regenerative Medicine and the Ludwig Center For Cancer Stem Cell Research & Medicine.
Dr. Weissman is a Professor at Stanford University since 1989.
Dr. Weissman is a Member of the National Academy of Sciences, the National Academy of Medicine (United States), the American Philosophical Society since 2008, the American Academy of Microbiology since 1997, and The American Association of Arts & Sciences.
Dr. Weissman is a Venture Partner at Catalio Capital Management LP.
Formerly, Dr. Weissman was Director at StemCells, Inc. from 1997 to 2016.
Dr. Weissman was an Advisor at MPM BioImpact LLC.
Dr. Weissman was a Member of the American Association for the Advancement of Science.
Dr. Weissman earned a doctorate from Stanford University in 1965 and an undergraduate degree from Montana State University in 1961.

Aktive Positionen von Irving Weissman

UnternehmenPositionBeginn
Corporate Officer/Principal 01.01.1989
Corporate Officer/Principal 01.01.2008
Institute For Stem Cell Biology & Regenerative Medicine
Direktor/Vorstandsmitglied -
Ludwig Center For Cancer Stem Cell Research & Medicine
Direktor/Vorstandsmitglied -
American Academy of Microbiology
Corporate Officer/Principal 01.01.1997
Corporate Officer/Principal -
Corporate Officer/Principal -
The American Association of Arts & Sciences
Corporate Officer/Principal -
Private Equity Investor -

Ehemalige bekannte Positionen von Irving Weissman

UnternehmenPositionEnde
░░░░░ ░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Irving Weissman im Detail an

Ausbildung von Irving Weissman

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

69

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen18

Health Technology

Health Services

Health Technology

Finance

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

American Academy of Microbiology

The American Association of Arts & Sciences

Health Technology

Institute For Stem Cell Biology & Regenerative Medicine

Ludwig Center For Cancer Stem Cell Research & Medicine

Finance

Health Technology

Health Technology

  1. Börse
  2. Insiders
  3. Irving Weissman